Effects of anticancer drugs on transcription factor–DNA interactions

The sequence of the human genome

Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909 · see citing works

NF-κB in cancer: from innocent bystander to major culprit

Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476 · see citing works

DNA and its associated processes as targets for cancer therapy

Hurley, L. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc749 · Cited by 1,350 · see citing works

The proteasome: a suitable antineoplastic target

Adams, J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1361 · Cited by 1,200 · see citing works

Transcription factors as targets for cancer therapy

Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · see citing works

The general transcription factors of RNA polymerase II.Preprint

Orphanides, G. M., Lagrange, T., & Reinberg, D. (1996) · Genes & Development · doi:10.1101/gad.10.21.2657 · Cited by 1,036 · see citing works

LNA (Locked Nucleic Acid):  High-Affinity Targeting of Complementary RNA and DNA

Vester, B., & Wengel, J. (2004) · Biochemistry · doi:10.1021/bi0485732 · Cited by 727 · see citing works

Intercalators as Anticancer Drugs

BRANA, M. F., Cacho, M., Gradillas, A., de Pascual‐Teresa, B., & Ramos, A. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397113 · Cited by 445 · see citing works

DNA minor groove binders as potential antitumor and antimicrobial agents

Baraldi, P. G., Bovero, A., Fruttarolo, F., Preti, D., Tabrizi, M. A., Pavani, M. G., & Romagnoli, R. (2004) · Medicinal Research Reviews · doi:10.1002/med.20000 · Cited by 377 · see citing works

The mitomycin bioreductive antitumor agents: Cross-linking and alkylation of DNA as the molecular basis of their activity

Tomasz, M., & Palom, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00088-0 · Cited by 285 · see citing works

The sequence of the human genome. Venter JC, Adams MD, Myers EW, et al. Science 2001;291:1304–1351.

Liesegang, T. J. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01077-7 · Cited by 276 · see citing works

Topoisomerase I Poisons and Suppressors as Anticancer Drugs

Bailly, C. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375489 · Cited by 267 · see citing works

Mechanism of action in thalidomide teratogenesis

Stephens, T. D., Bunde, C. J. W., & Fillmore, B. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00388-3 · Cited by 259 · see citing works

Triple helix formation and the antigene strategy for sequence-specific control of gene expression.

Praseuth, D., Guieysse, A., & Héléne, C. (1999) · Biochimica et Biophysica Acta · doi:10.1016/s0167-4781(99)00149-9 · Cited by 242 · see citing works

Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands

Dickinson, L. A., Gulizia, R. J., Trauger, J. W., Baird, E. E., Mosier, D. E., Gottesfeld, J. M., & Dervan, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12890 · Cited by 219 · see citing works

Targeting the p53–MDM2 interaction to treat cancer

Klein, C., & Vassilev, L. T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602164 · Cited by 204 · see citing works

Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells

Abdelrahim, M., Smith, R., Burghardt, R. C., & Safe, S. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0713 · Cited by 199 · see citing works

Trisubstituted Acridine Derivatives as Potent and Selective Telomerase Inhibitors

Harrison, R. J., Cuesta, J., Chessari, G., Read, M. A., Basra, S. K., Reszka, A. P., Morrell, J. M., Gowan, S. M., Incles, C. M., Tanious, F. A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0308693 · Cited by 185 · see citing works

Methidiumpropyl-EDTA-Fe(II) and DNase I footprinting report different small molecule binding site sizes on DNA

Dyke, M. W. V., & Dervan, P. B. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.16.5555 · Cited by 175 · see citing works

Cisplatin‐ and UV‐damaged DNA lure the basal transcription factor TFIID/TBP

Vichi, P., Coin, F., Renaud, J., Vermeulen, W., Hoeijmakers, J. H. J., Moras, D., & Egly, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7444 · Cited by 172 · see citing works

A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence.

Grigoriev, M., Praseuth, D., Robin, P., Hémar, A., Saison-Behmoaras, T. E., Dautry‐Varsat, A., Thuong, N. T., Hélène, C., & Harel‐Bellan, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50743-8 · Cited by 167 · see citing works

Dual Topoisomerase I / II Inhibitors in Cancer Therapy

Denny, W. A., & Baguley, B. C. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452555 · Cited by 153 · see citing works

Telomeres and telomerases as drug targets

Rezler, E. M. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00182-0 · Cited by 146 · see citing works

Pyrrolo[1,4]benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds

Hurley, L. H., Reck, T., Thurston, D. E., Langley, D. R., Holden, K. G., Hertzberg, R., Hoover, J. R. E., Gallagher, G., & Faucette, L. F. (1988) · Chemical Research in Toxicology · doi:10.1021/tx00005a002 · Cited by 140 · see citing works

Antisense therapeutics: is it as simple as complementary base recognition?

Agrawal, S., & Kandimalla, E. R. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01638-x · Cited by 140 · see citing works

Transmission of stability (telestability) in deoxyribonucleic acid. Physical and enzymatic studies on the duplex block polymer d(C15A15) - d(T15G15).

Burd, J. F., Wartell, R. M., Dodgson, J. B., & Wells, R. D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41284-2 · Cited by 133 · see citing works

EUKARYOTIC TRANSCRIPTION FACTOR-DNA COMPLEXES

Patikoglou, G. A., & Burley, S. K. (1997) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.26.1.289 · Cited by 133 · see citing works

Induction of p53 and p21WAF1CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells

Ho, Y., Wang, Y., & Lin, J. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199605)16:1 · Cited by 131 · see citing works

Dual Blockade of Cyclic AMP Response Element- (CRE) and AP-1-directed Transcription by CRE-transcription Factor Decoy Oligonucleotide

Park, Y. G., Nesterova, M., Agrawal, S., & Cho‐Chung, Y. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1573 · Cited by 126 · see citing works

Sequence‐selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons

Chatterjee, S., Zaman, K., Ryu, H., Conforto, A. B., & Ratan, R. R. (2001) · Annals of Neurology · doi:10.1002/ana.71.abs · Cited by 126 · see citing works

Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates

Belitsky, J. M. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00204-3 · Cited by 112 · see citing works

DNA intercalating anti-tumour agents.

Bc, B. (1991) · PubMed · Cited by 107 · see citing works

Relationships between DNA-binding kinetics and biological activity for the 9-aminoacridine-4-carboxamide class of antitumor agents

Wakelin, L. P. G., Atwell, G. J., Rewcastle, G. W., & Denny, W. A. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00388a019 · Cited by 104 · see citing works

Defining GC-specificity in the minor groove: side-by-side binding of the di-imidazole lexitropsin to C-A-T-G-G-C-C-A-T-G

Kopka, M. L., Goodsell, D. S., Han, G. W., Chiu, T. K., Lown, J. W., & Dickerson, R. E. (1997) · Structure · doi:10.1016/s0969-2126(97)00255-4 · Cited by 104 · see citing works

Proteins that specifically recognize cisplatin‐damaged DNA: a clue to anticancer activity of cisplatin

Zlatanova, J. S., Yaneva, J. N., & Leuba, S. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.791 · Cited by 99 · see citing works

Interaction of FACT, SSRP1, and the High Mobility Group (HMG) Domain of SSRP1 with DNA Damaged by the Anticancer Drug Cisplatin

YARNELL, A., Oh, S., Reinberg, D., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101208200 · Cited by 96 · see citing works

Cell cycle control and cancer chemotherapy

Kohn, K. W., Jackman, J., & O'Connor, P. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540411 · Cited by 96 · see citing works

Energetics of echinomycin binding to DNA

Leng, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg826 · Cited by 96 · see citing works

Targeting DNA-binding drugs to sequence-specific transcription factor.DNA complexes. Differential effects of intercalating and minor groove binding drugs.

Welch, J. J., Rauscher, F. J., & Beerman, T. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47389-9 · Cited by 90 · see citing works

DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin

Broggini, M., Coley, H. M., Mongelli, N., Pesenti, E. A., Wyatt, M. D., Hartley, J. A., & D’Incalci, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.1.81 · Cited by 90 · see citing works

Transcription Factor Decoy Molecules Based on a Peptide Nucleic Acid (PNA)-DNA Chimera Mimicking Sp1 Binding Sites

Borgatti, M., Lampronti, I., Romanelli, A., Pedone, C., Saviano, M., Bianchi, N., Mischiati, C., & Gambari, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206780200 · Cited by 84 · see citing works

Effects of Spectator Ligands on the Specific Recognition of Intrastrand Platinum-DNA Cross-links by High Mobility Group Box and TATA-binding Proteins

Wei, M., Cohen, S. M., Silverman, A. P., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106374200 · Cited by 79 · see citing works

Differential Rates of Reversibility of Ecteinascidin 743−DNA Covalent Adducts from Different Sequences Lead to Migration to Favored Bonding Sites

Zewail‐Foote, M., & Hurley, L. H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja004023p · Cited by 78 · see citing works

Human Testis-Determining Factor SRY Binds to the Major DNA Adduct of Cisplatin and a Putative Target Sequence with Comparable Affinities

Trimmer, E. E., Zamble, D. B., Lippard, S. J., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi971675q · Cited by 78 · see citing works

Triplex-forming molecules: from concepts to applications

Faria, M., & Giovannangeli, C. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.192 · Cited by 77 · see citing works

Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function.

Uhlmann, E. J. (1998) · PubMed · Cited by 76 · see citing works

Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA.

Bonfanti, M., Valle, E. L., Faro, J. M. F. S., Faircloth, G. T., Caretti, G., Mantovani, R., & D’Incalci, M. (1999) · PubMed · Cited by 76 · see citing works

Inhibition of Ets-1 DNA Binding and Ternary Complex Formation between Ets-1, NF-κB, and DNA by a Designed DNA-binding Ligand

Dickinson, L. A., Trauger, J. W., Baird, E. E., Dervan, P. B., Graves, B. J., & Gottesfeld, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12765 · Cited by 71 · see citing works

Transcription factors and neoplasia: vistas in novel drug design.

Karamouzis, M. V., Gorgoulis, V. G., & Papavassiliou, A. G. (2002) · PubMed · Cited by 71 · see citing works

Interaction of the Human NF-κB p52 Transcription Factor with DNA-PNA Hybrids Mimicking the NF-κB Binding Sites of the Human Immunodeficiency Virus Type 1 Promoter

Mischiati, C., Borgatti, M., Bianchi, N., Rutigliano, C., Tomassetti, M., Feriotto, G., & Gambari, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33114 · Cited by 67 · see citing works

Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity

Palanki, M. S. S. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371265 · Cited by 66 · see citing works

Crystal structures of the side-by-side binding of distamycin to AT-containing DNA octamers d(ICITACIC) and d(ICATATIC)

Chen, X., Ramakrishnan, B., & Sundaralingam, M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0941 · Cited by 64 · see citing works

In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells.

Samuel, S. K., Spencer, V. A., Bajno, L., Sun, J.-M., Holth, L. T., Oesterreich, S., & Davie, J. (1998) · PubMed · Cited by 63 · see citing works

Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription

Bellorini, M., Moncollin, V., D’lncalci, M., Mongelli, N., & Mantovani, R. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1657 · Cited by 62 · see citing works

Adriamycin-induced DNA Adducts Inhibit the DNA Interactions of Transcription Factors and RNA Polymerase

Cutts, S. M., Parsons, P. G., Sturm, R. A., & Phillips, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5422 · Cited by 58 · see citing works

FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo

Beckerbauer, L., Tepe, J. J., Cullison, J., Reeves, R., & Williams, R. M. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00028-4 · Cited by 57 · see citing works

A Comparison of DNA-Binding Drugs as Inhibitors of E2F1− and Sp1−DNA Complexes and Associated Gene Expression

Chiang, S.-Y., Azizkhan, J. C., & Beerman, T. A. (1998) · Biochemistry · doi:10.1021/bi9721142 · Cited by 56 · see citing works

Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists.

Ho, S. N., Boyer, S. H., Schreiber, S. L., Danishefsky, S. J., & Crabtree, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9203 · Cited by 56 · see citing works

Targeting the Ets Binding Site of the HER2/neuPromoter with Pyrrole-Imidazole Polyamides

Chiang, S.-Y., Bürli, R. W., Benz, C. C., Gawron, L. S., Scott, G. K., Dervan, P. B., & Beerman, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000820200 · Cited by 56 · see citing works

DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate

Wang, Y. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg215 · Cited by 54 · see citing works

Transcription Factors As Targets for DNA-Interacting Drugs

Gniazdowski, M., Denny, W., Nelson, S., & Czyz, M. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457683 · Cited by 52 · see citing works

DNA damage repair and transcription

Bowen, N. J., Palmer, M. B., & Wade, P. A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4177-x · Cited by 52 · see citing works

Anti-repression of RNA Polymerase II Transcription by Pyrrole−Imidazole Polyamides

Dickinson, L. A., Trauger, J. W., Baird, E. E., Ghazal, P., Dervan, P. B., & Gottesfeld, J. M. (1999) · Biochemistry · doi:10.1021/bi9912847 · Cited by 51 · see citing works

Structural basis of DNA recognition by anticancer antibiotics, chromomycin A3, and mithramycin: Roles of minor groove width and ligand flexibility

Chakrabarti, S., Bhattacharyya, D., & Dasgupta, D. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)56:2 · Cited by 51 · see citing works

Dissection of the free energy of anthracycline antibiotic binding to DNA: electrostatic contributions

Chaires, J. B., Priebe, W., Graves, D. E., & Burke, T. G. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00066a002 · Cited by 49 · see citing works

Composition and conservation of the telomeric complex

Kanoh, J., & Ishikawa, F. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3245-y · Cited by 49 · see citing works

Inhibition of Ribonucleic Acid-Polymerase Reactions by Actinomycin and Proflavine

GOLDBERG, I. H., Reich, E., & Rabinowitz, M. (1963) · Nature · doi:10.1038/199044a0 · Cited by 49 · see citing works

Aptamers containing thymidine 3′-O-phosphorodithioates: Synthesis and binding to nuclear factor-κB

Yang, X., Fennewald, S. M., Luxon, B. A., Aronson, J. F., Herzog, N. K., & Gorenstein, D. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00600-9 · Cited by 46 · see citing works

Analysis of the Effects of Daunorubicin and WP631 on Transcription

Portugal, J., Martin, B., Vaquero, A., Ferrer‐Miralles, N., Villamarı́n, S., & Priebe, W. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373976 · Cited by 44 · see citing works

Nuclear Targeting and Nuclear Retention of Anthracycline−Formaldehyde Conjugates Implicates DNA Covalent Bonding in the Cytotoxic Mechanism of Anthracyclines

Taatjes, D. J., Fenick, D. J., & Koch, T. H. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990008q · Cited by 44 · see citing works

Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor

Rink, S. M., Yarema, K. J., Solomon, M. S., Paige, L. A., Tadayoni-Rebek, B. M., Essigmann, J. M., & Croy, R. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15063 · Cited by 43 · see citing works

Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity

Crinelli, R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh503 · Cited by 41 · see citing works

The Effects of DNA Covalent Adducts on in Vitro Transcription

Gniazdowski, M., & Cera, C. (1996) · Chemical Reviews · doi:10.1021/cr940049l · Cited by 41 · see citing works

Inhibition of DNA Binding by NF-κB with Pyrrole-Imidazole Polyamides

Wurtz, N. R., Pomerantz, J. L., Baltimore, D., & Dervan, P. B. (2002) · Biochemistry · doi:10.1021/bi020114i · Cited by 40 · see citing works

Peptide Nucleic Acids: On the Road to New Gene Therapeutic Drugs

Nielsen, P. E. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.pto860102.x · Cited by 37 · see citing works

Recognition of Ten Base Pairs of DNA by Head-to-Head Hairpin Dimers

Weyermann, P., & Dervan, P. B. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020258k · Cited by 37 · see citing works

Modulation of transcription factor--DNA interactions by anticancer drugs.

Broggini, M., & D’Incalci, M. (1994) · PubMed · Cited by 37 · see citing works

The Genome as a Drug Target Sequence Specific Minor Groove Binding Ligands

Turner, P., & Denny, W. A. (2000) · Current Drug Targets · doi:10.2174/1389450003349407 · Cited by 36 · see citing works

Sequence-dependent termination of bacteriophage T7 transcription in vitro by DNA-binding drugs

White, R. J., & Phillips, D. R. (1989) · Biochemistry · doi:10.1021/bi00436a024 · Cited by 36 · see citing works

Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide

MacLeod, M. C., Powell, K. L., & Ngoc, T. (1995) · Carcinogenesis · doi:10.1093/carcin/16.5.975 · Cited by 35 · see citing works

p53 binds to cisplatin-damaged DNA

Wetzel, C. C., & Berberich, S. J. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00305-5 · Cited by 34 · see citing works

Search for the Optimal Linker in Tandem Hairpin Polyamides

Kers, I. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00221-3 · Cited by 34 · see citing works

Cisplatin−DNA Binding Specificity of Calf High-Mobility Group 1 Protein

Turchi, J. J., Li, M., & Henkels, K. M. (1996) · Biochemistry · doi:10.1021/bi951843j · Cited by 33 · see citing works

Sequence specificity of formaldehyde-mediated covalent binding of anthracycline derivatives to DNA

Szuławska, A., Gniazdowski, M., & Czyż, M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.002 · Cited by 32 · see citing works

Kinetic Studies of the TATA-binding Protein Interaction with Cisplatin-modified DNA

Jung, Y., Mikata, Y., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108299200 · Cited by 32 · see citing works

Promoter Scanning for Transcription Inhibition with DNA-Binding Polyamides

Ehley, J. A., Melander, C., Herman, D., Baird, E. E., Ferguson, H. A., Goodrich, J. A., Dervan, P. B., & Gottesfeld, J. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1723-1733.2002 · Cited by 32 · see citing works

A 3·(ET743)-DNA Complex That Both Resembles an RNA-DNA Hybrid and Mimicks Zinc Finger-Induced DNA Structural Distortions

Marco, E., Garcı́a-Nieto, R., Mendieta, J., Manzanares, I., Cuevas, C., & Gago, F. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010370d · Cited by 31 · see citing works

The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation

Taylor, A., Webster, K. A., Gustafson, T. A., & Kedes, L. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006898812618 · Cited by 31 · see citing works

Thalidomide Down-Regulates Transcript Levels of GC-Rich Promoter Genes in Multiple Myeloma

Drucker, L., Uziel, O., Tohami, T., Shapiro, H., Radnay, J., Yarkoni, S., Lahav, M., & Lishner, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.415 · Cited by 30 · see citing works

Attenuation of interleukin-8 production by inhibiting nuclear factor-κB translocation using decoy oligonucleotides∗

Cooper, J. A. D., Parks, J. M., Carcelen, R., Kahlon, S. S., Sheffield, M., & Culbreth, R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00375-5 · Cited by 30 · see citing works

Gene targets of antisense therapies in breast cancer

Yang, D. C., Head, J. F., & Elliott, R. L. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.3.375 · Cited by 29 · see citing works

Cell-free and Cellular Activities of a DNA Sequence Selective Hairpin Polyamide-CBI Conjugate

Wang, Y., Dziegielewski, J., Chang, A. Y., Dervan, P. B., & Beerman, T. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207179200 · Cited by 28 · see citing works

Targeting E2F1–DNA complexes with microgonotropen DNA binding agents

Chiang, S.-Y., Bruice, T. C., Azizkhan, J. C., Gawron, L. S., & Beerman, T. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2811 · Cited by 28 · see citing works

Decoy Oligodeoxynucleotide Characterization of Transcription Factors Controlling Endothelin-B Receptor Expression in Vascular Smooth Muscle Cells

Wagner, A. H., Krzesz, R., Gao, D., Schroeder, C., Cattaruzza, M., & Hecker, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1333 · Cited by 28 · see citing works

DNA damage repair and transcription

Berardi, P., Russell, M., El‐Osta, A., & Riabowol, K. T. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4179-8 · Cited by 28 · see citing works

Psoralen adducts induced by triplex-forming oligonucleotides are refractory to repair in HeLa cells 1 1Edited by M. Yaniv

Guieysse‐Peugeot, A., Praseuth, D., Giovannangeli, C., Asseline, U., & Hélène, C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3466 · Cited by 27 · see citing works

TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycin

Sun, D., & Hurley, L. H. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90263-5 · Cited by 26 · see citing works

Evaluation of the Effectiveness of DNA-Binding Drugs To Inhibit Transcription Using the c-fos Serum Response Element as a Target

White, C. M., Heidenreich, O. T., Nordheim, A., & Beerman, T. A. (2000) · Biochemistry · doi:10.1021/bi001427l · Cited by 25 · see citing works

Inhibition of transcription factor-DNA complexes and gene expression by a microgonotropen

White, C. M., Satz, A. L., Bruice, T. C., & Beerman, T. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191374698 · Cited by 25 · see citing works

Molecular approaches to achieving control of gene expression by drug intervention at the transcriptional level.

Zewail‐Foote, M., & Hurley, L. H. (1999) · PubMed · Cited by 25 · see citing works

Sp1-Targeted Inhibition of Gene Transcription by WP631 in Transfected Lymphocytes

Mansilla, S., Priebe, W., & Portugal, J. (2004) · Biochemistry · doi:10.1021/bi036185e · Cited by 24 · see citing works

Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin

Bianchi, N., Passadore, M., Rutigliano, C., Feriotto, G., Mischiati, C., & Gambari, R. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00510-2 · Cited by 24 · see citing works

Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin

Kašpárková, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh896 · Cited by 23 · see citing works

New cancer therapeutics: target-specific in, cytotoxics out?

Broxterman, H. J., & Georgopapadakou, N. H. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.02.004 · Cited by 22 · see citing works

Effects of quinacrine on endothelial cell morphology and transcription factor–DNA interactions

Stuhlmeier, K. M. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00140-9 · Cited by 22 · see citing works

Osteoblastic Differentiation Induced by Transcription Factor Decoy against Estrogen Receptor α Gene

Lambertini, E., Penolazzi, L., Aguiari, G., SENNO, L. D., Pezzetti, F., Sollazzo, V., & Piva, R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6708 · Cited by 21 · see citing works

Targeting critical regions in genomic DNA with AT-specific anticancer drugs

WOYNAROWSKI, J. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00093-5 · Cited by 21 · see citing works

Transcription factors as drug targets in cancer

Hurst, H. C. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00214-6 · Cited by 21 · see citing works

Combinatorial Determination of Sequence Specificity for Nanomolar DNA-Binding Hairpin Polyamides

Gopal, Y. N. V., & Dyke, M. W. V. (2003) · Biochemistry · doi:10.1021/bi027373s · Cited by 20 · see citing works

Inhibition of major groove DNA binding bZIP proteins by positive patch polyamides.

Bremer, R., Wurtz, N. R., Szewczyk, J., & Dervan, P. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00122-5 · Cited by 19 · see citing works

Recent developments in antiangiogenic therapy

Dredge, K. S., Dalgleish, A. G., & Marriott, J. B. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.8.953 · Cited by 17 · see citing works

Transplatin-modified oligonucleotides as modulators of gene expression

Giraud-Panis, M.-J. E., & Leng, M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00058-3 · Cited by 16 · see citing works

A microgonotropen branched decaaza decabutylamine and its DNA and DNA/transcription factor interactions

Bruice, T. C., Sengupta, D., Blaskó, A., Chiang, S.-Y., & Beerman, T. A. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00011-4 · Cited by 16 · see citing works

New dsDNA binding unnatural oligopeptides with pyrimidine selectivity

Zhang, Z., Chaltin, P., Aerschot, A. A. V., Lacey, J., Rozenski, J., Busson, R. H., & Herdewijn, P. A. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00268-7 · Cited by 16 · see citing works

Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.

Mano, Y., Shimizu, T., Tanuma, S.-I., & Takeda, K. (2000) · PubMed · Cited by 16 · see citing works

bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells

Amstad, P., Liu, H., Ichimiya, M., Chang, S. H., Berezesky, I. K., & Trump, B. F. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199710)20:2 · Cited by 15 · see citing works

Actinomycin D specifically inhibits the interaction between transcription factor Sp1 and its binding site.

Czyż, M., & Gniazdowski, M. (1998) · Acta Biochimica Polonica · doi:10.18388/abp.1998_4319 · Cited by 14 · see citing works

Sequence selective binding of bis‐daunorubicin WP631 to DNA

Fox, K. R., Webster, R. A. B., Phelps, R. J., Fokt, I., & Priebe, W. (2004) · European Journal of Biochemistry · doi:10.1111/j.0014-2956.2004.04292.x · Cited by 13 · see citing works

Amiodarone for Rapid Cardioversion of Chronic Atrial Tachyarrhythmia?

Nielsen, K. D., & Møller, S. (2000) · Pharmacology & Toxicology · doi:10.1111/j.0901-9928.2000.860607.x · Cited by 12 · see citing works

Transcription factors as targets of anticancer drugs.

Gniazdowski, M., & Czyż, M. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4159 · Cited by 10 · see citing works

A Thymine:Thymine Mismatch Enhances the Pluramycin Alkylation Site Downstream of the TBP−TATA Box Complex

Lee, S., & Hurley, L. H. (1999) · Journal of the American Chemical Society · doi:10.1021/ja991607m · Cited by 9 · see citing works

Binding of Sp1 to the 21-bp repeat region of SV40 DNA: effect of intrinsic and drug-induced DNA bending between GC boxes

Sun, D., & Hurley, L. H. (1994) · Gene · doi:10.1016/0378-1119(94)90425-1 · Cited by 8 · see citing works

Anthraquinone-peptides as inhibitors of AP-1 transcription factor

Ijaz, T., Tran, P., Ruparelia, K. C., Teesdale‐Spittle, P. H., Orr, S., & Patterson, L. H. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00653-3 · Cited by 7 · see citing works

Mono- and dysfunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA.

Smaill, J. B., Fan, J.-Y., Papa, P., OʼConnor, C. J., & Denny, W. A. (1998) · PubMed · Cited by 6 · see citing works

The effect of DNA-alkylating agents on gene expression from two integrated reporter genes in a mouse mammary tumor line

Gieseg, M. A., de Bock, C. E., Turner, P. M., Ferguson, L. R., & Denny, W. A. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200203000-00009 · Cited by 2 · see citing works

Targeting transcription factors in cancer — from undruggable to reality

Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919 · see citing works

Sp1 transcription factor: A long-standing target in cancer chemotherapy

Vizcaíno, C., Mansilla, S., & Portugal, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.008 · Cited by 437 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Non-covalent ligand/DNA interactions: Minor groove binding agents

Nelson, S. M., Ferguson, L. R., & Denny, W. A. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.03.012 · Cited by 165 · see citing works

Understanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice

Vellingiri, B., Iyer, M., Subramaniam, M. D., Jayaramayya, K., Siama, Z., Giridharan, B., Narayanasamy, A., Dayem, A. A., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031153 · Cited by 98 · see citing works

Regulating Toxin-Antitoxin Expression: Controlled Detonation of Intracellular Molecular Timebombs

Hayes, F., & Kędzierska, B. (2014) · Toxins · doi:10.3390/toxins6010337 · Cited by 93 · see citing works

Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs

Szumilak, M., Szuławska‐Mroczek, A., Koprowska, K., Stasiak, M., Lewgowd, W., Stańczak, A., & Czyż, M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.032 · Cited by 64 · see citing works

DNA‐Binding Small Molecules as Inhibitors of Transcription Factors

Leung, C., Chan, D. S., Ma, V. P., & Ma, D. (2013) · Medicinal Research Reviews · doi:10.1002/med.21266 · Cited by 58 · see citing works

Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication

Peixoto, P., Liu, Y., Depauw, S., Hildebrand, M., Boykin, D. W., Bailly, C., Wilson, W. D., & David‐Cordonnier, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn208 · Cited by 52 · see citing works

Depurinating Acylfulvene−DNA Adducts: Characterizing Cellular Chemical Reactions of a Selective Antitumor Agent

Gong, J., Vaidyanathan, V. G., Yu, X. Y., Kensler, T. W., Peterson, L. A., & Sturla, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0665951 · Cited by 51 · see citing works

DNA‐Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular Consequences

Lenglet, G., & David‐Cordonnier, M. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/290935 · Cited by 50 · see citing works

Sp1 transcription factor as a target for anthracyclines: Effects on gene transcription

Mansilla, S., & Portugal, J. (2008) · Biochimie · doi:10.1016/j.biochi.2007.12.008 · Cited by 42 · see citing works

Metal complexes as inhibitors of transcription factor activity

Leung, C., He, H., Liu, L., Wang, M., Chan, D. S., & Ma, D. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.08.008 · Cited by 40 · see citing works

Evaluation of flavonoids binding to DNA duplexes by electrospray ionization mass spectrometry

Zhaofu, W., Cui, M., Song, F., Lin, L., Liu, Z., & Liu, S. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.04.018 · Cited by 40 · see citing works

Childhood Acute Lymphoblastic Leukemia Survivors Have a Substantially Lower Cardiorespiratory Fitness Level Than Healthy Canadians Despite a Clinically Equivalent Level of Physical Activity

Caru, M., Samoilenko, M., Drouin, S., Lemay, V., Kern, L., Romo, L., Bertout, L., Lefebvre, G., Andelfinger, G., Krajinović, M., et al. (2019) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2019.0024 · Cited by 36 · see citing works

A novel insight into the cytotoxic effects of Tephrosin with calf thymus DNA: Experimental and in silico approaches

Dehkordi, M. F., Darzi, S., Rahmani, B., & Farhadian, S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114728 · Cited by 35 · see citing works

Studies on alkaloids binding to GC‐rich human survivin promoter DNA using positive and negative ion electrospray ionization mass spectrometry

Wang, Z., Guo, X., Liu, Z., Cui, M., Song, F., & Liu, S. (2007) · Journal of Mass Spectrometry · doi:10.1002/jms.1320 · Cited by 27 · see citing works

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells

Congras, A., Caillet, N., Torossian, N., Quelen, C., Daugrois, C., Brousset, P., Lamant, L., Meggetto, F., & Hoareau‐Aveilla, C. (2018) · Oncotarget · doi:10.18632/oncotarget.24465 · Cited by 27 · see citing works

A diarylamine derived from anthranilic acid inhibits ZIKV replication

Silva, S., Shimizu, J. F., de Oliveira, D. M., de Assis, L. R., Bittar, C., Mottin, M., Sousa, B. K. D. P., Mesquita, N. C. D. M. R., Regasini, L. O., Rahal, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54169-z · Cited by 25 · see citing works

Challenging transcription by DNA-binding antitumor drugs

Portugal, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.030 · Cited by 25 · see citing works

Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activity

Portugal, J. (2009) · BMC Pharmacology · doi:10.1186/1471-2210-9-11 · Cited by 22 · see citing works

Study of DNA interactions with cyclic chalcone derivatives by spectroscopic techniques

Štefanišinová, M., Tomečková, V., Kožurková, M., Ostro, A., & Mareková, M. (2011) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2011.06.071 · Cited by 20 · see citing works

Novel mithramycins abrogate the involvement of protein factors in the transcription of cell cycle control genes

Vizcaíno, C., Mansilla, S., Núñez, L. E., Méndez, C., Salas, J. A., Morís, F., & Portugal, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.003 · Cited by 18 · see citing works

Controlled Sequestration of DNA Intercalated Drug by Polymer–Surfactant Supramolecular Assemblies

Mora, A. K., Singh, P. K., & Nath, S. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b12689 · Cited by 17 · see citing works

Selective inhibition of yeast regulons by daunorubicin: A transcriptome-wide analysis

Rojas, M., Casado, M., Portugal, J., & Piña, B. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-358 · Cited by 14 · see citing works

Selective binding of small molecules to DNA: Application and perspectives

Wang, B., Tan, J., & Zhu, L. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.03.048 · Cited by 13 · see citing works

Identification of genetic association between cardiorespiratory fitness and the trainability genes in childhood acute lymphoblastic leukemia survivors

Caru, M., Petrykey, K., Drouin, S., Beaulieu, P., St-Onge, P., Lemay, V., Bertout, L., Laverdière, C., Andelfinger, G., Krajinović, M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5651-z · Cited by 13 · see citing works

Peptidosteroid Tweezers Revisited: DNA Binding Through an Optimised Design

Carrette, L. L. G., Morii, T., & Madder, A. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201301854 · Cited by 12 · see citing works

Chromatin as a Target for the DNA-Binding Anticancer Drugs

Majumder, P., Pradhan, S. K., Devi, P. G., Pal, S., & Dasgupta, D. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_8 · Cited by 11 · see citing works

Advances in transcription factor delivery: Target selection, engineering strategies, and delivery platforms

Lee, Y., Yoo, S., Cho, S., Kim, I., & Kim, I.-S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113885 · Cited by 9 · see citing works

Study on noncovalent complexes of alkaloids with DNA duplex using electrospray ionization mass spectrometry

Ma, L., Song, F., Liu, Z., & Liu, S. (2012) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6424 · Cited by 9 · see citing works

Transcriptional Control of Toxin–Antitoxin Expression: Keeping Toxins Under Wraps Until the Time is Right

Kędzierska, B., & Hayes, F. (2016) · doi:10.1002/9781119004813.ch42 · Cited by 9 · see citing works

Sex and Gender Considerations After Surviving Acute Lymphoblastic Leukemia: An Exercise Oncology Context

Caru, M., & Curnier, D. Y. (2020) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2019.0137 · Cited by 7 · see citing works

Peptide scalpels for site-specific dissection of the DNA–protein interface

Verzele, D., Carrette, L. L. G., & Madder, A. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.03.001 · Cited by 7 · see citing works

Insights into DNA‐drug interactions in the era of omics

Portugal, J. (2020) · Biopolymers · doi:10.1002/bip.23385 · Cited by 5 · see citing works

Changes in gene expression induced by Sp1 knockdown differ from those caused by challenging Sp1 binding to gene promoters

Mansilla, S., Priebe, W., & Portugal, J. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.06.003 · Cited by 3 · see citing works

Evaluation of Flavonoids Binding to DNA Duplexes by Electrospray Ionization

Zhaofu, W., Cui, M., Song, F., Lü, L., Liu, Z., & Liu, S. (2008)

Synthetic Approaches and Challenges to Transcription Factor Inhibitors

Procopiou, G., & Procopiou, P. A. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781782624011-00001

Prévention des neuropathies périphériques induites par les chimiothérapies par une modulation pharmacologique des dérives des formes réactives de l'oxygène et des récepteurs muscariniques

Cerles, O. (2017) · doi:10.70675/5734b561zdbcez47fdz9079zd20120eca3be

Rôle de la méthylation de l'ADN et des microARN dans les lymphomes T anaplasiques à grandes cellules ALK positifs

Caillet, N. (2019) · doi:10.70675/54739fcaz12d2z4403z9720z7664dce5b49b

Étude des effets de l’activité physique en oncologie pédiatrique : des paramètres physiologiques aux paramètres psychologiques

Caru, M. (2020) · doi:10.70675/5d9e02bezf43az458czadb5zba6f8227055c

Transcription Factors As Targets for DNA-Interacting Drugs

Gniazdowski, M., Denny, W., Nelson, S., & Czyz, M. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457683 · Cited by 52 · see citing works

Transcription factors as targets of anticancer drugs.

Gniazdowski, M., & Czyż, M. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4159 · Cited by 10 · see citing works

Challenging transcription by DNA-binding antitumor drugs

Portugal, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.030 · Cited by 25 · see citing works

Modulation of transcription factor--DNA interactions by anticancer drugs.

Broggini, M., & D’Incalci, M. (1994) · PubMed · Cited by 37 · see citing works

Transcriptional Footprinting of Drug–DNA Interactions

Phillips, D. R., & Cullinane, C. M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-447-x:127 · Cited by 1 · see citing works